Autocrine Endothelin-3/Endothelin Receptor B Signaling Maintains Cellular and Molecular Properties of Glioblastoma Stem Cells

Glioblastoma stem cells (GSC) express both radial glial cell and neural crest cell (NCC)-associated genes. We report that endothelin 3 (EDN3), an essential mitogen for NCC development and migration, is highly produced by GSCs. Serum-induced proliferative differentiation rapidly decreased EDN3 production and downregulated the expression of stemness-associated genes, and reciprocally, two glioblastoma markers, EDN1 and YKL-40 transcripts, were induced. Correspondingly, patient glioblastoma tissues express low levels of EDN3 mRNA and high levels of EDN1 and YKL-40 mRNA. Blocking EDN3/EDN receptor B (EDNRB) signaling by an EDNRB antagonist (BQ788), or EDN3 RNA interference (siRNA), leads to cell apoptosis and functional impairment of tumor sphere formation and cell spreading/migration in culture and loss of tumorigenic capacity in animals. Using exogenous EDN3 as the sole mitogen in culture does not support GSC propagation, but it can rescue GSCs from undergoing cell apoptosis. Molecular analysis by gene expression profiling revealed that most genes downregulated by EDN3/EDNRB blockade were those involved in cytoskeleton organization, pause of growth and differentiation, and DNA damage response, implicating the involvement of EDN3/EDNRB signaling in maintaining GSC migration, undifferentiation, and survival. These data suggest that autocrine EDN3/EDNRB signaling is essential for maintaining GSCs. Incorporating END3/EDNRB-targeted therapies into conventional cancer treatments may have clinical implication for the prevention of tumor recurrence. Mol Cancer Res; 9(12); 1668–85. ©2011 AACR.

[1]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[2]  E. Domany,et al.  Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Janzer,et al.  The Endothelin System in Human Glioblastoma , 2000, Laboratory Investigation.

[4]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[5]  M. Westphal,et al.  Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria , 2008, Oncogene.

[6]  A. Goldstein,et al.  Endothelin-3 regulates neural crest cell proliferation and differentiation in the hindgut enteric nervous system. , 2006, Developmental biology.

[7]  D. Lloyd,et al.  Expression of endothelin 3 by mesenchymal cells of embryonic mouse caecum , 1999, Gut.

[8]  A. Munnich,et al.  Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome) , 1996, Nature Genetics.

[9]  G. Brüning,et al.  The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development. , 1994, Development.

[10]  D. Farkas,et al.  Isolation of cancer stem cells from adult glioblastoma multiforme , 2004, Oncogene.

[11]  Mahendra Rao,et al.  SOX2, a Persistent Marker for Multipotential Neural Stem Cells Derived from Embryonic Stem Cells, the Embryo or the Adult , 2004, Developmental Neuroscience.

[12]  R. Halaban,et al.  Identification of p90RSK as the probable CREB-Ser133 kinase in human melanocytes. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[13]  J. Rubenstein,et al.  Id4 regulates neural progenitor proliferation and differentiation in vivo , 2004, Development.

[14]  Errol M. Thomson,et al.  Pulmonary Expression of PreproET-1 and PreproET-3 mRNAs Is Altered Reciprocally in Rats After Inhalation of Air Pollutants , 2006, Experimental biology and medicine.

[15]  I. Weissman,et al.  Direct isolation of human central nervous system stem cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Hajime Nakano,et al.  Epistatic connections between microphthalmia‐associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Levin.  Mechanisms of disease : endothelins , 1995 .

[19]  M. Winslet,et al.  Endothelin receptor antagonism and cancer , 2009, European journal of clinical investigation.

[20]  Daniel H. Geschwind,et al.  Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Esteller,et al.  Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer , 2009, Breast Cancer Research.

[22]  C. Mitaka,et al.  Effects of TNF-alpha on hemodynamic changes and circulating endothelium-derived vasoactive factors in dogs. , 1994, The American journal of physiology.

[23]  K. Tanzawa,et al.  Cloning and functional expression of human endothelin-converting enzyme cDNA. , 1995, Biochemical and biophysical research communications.

[24]  D. Champeval,et al.  Endothelin 3 selectively promotes survival and proliferation of neural crest-derived glial and melanocytic precursors in vitro. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Herlyn,et al.  Endothelin-3 stimulates survival of goblet cells in organotypic cultures of fetal human colonic epithelium. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[26]  Alexander Brawanski,et al.  CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. , 2007, Cancer research.

[27]  A. McCallion,et al.  EDNRB/EDN3 and Hirschsprung disease type II. , 2001, Pigment cell research.

[28]  J. Udagawa,et al.  Gi2 Signaling Enhances Proliferation of Neural Progenitor Cells in the Developing Brain* , 2004, Journal of Biological Chemistry.

[29]  S. Mani,et al.  Failure to express GAP-43 leads to disruption of a multipotent precursor and inhibits astrocyte differentiation , 2004, Molecular and Cellular Neuroscience.

[30]  R. DePinho,et al.  Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.

[31]  Paolo Malatesta,et al.  SOX2 Silencing in Glioblastoma Tumor‐Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity , 2009, Stem cells.

[32]  Guido Nikkhah,et al.  NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts , 2009, Stem cells.

[33]  T. P. Rothman,et al.  Inhibition of in vitro enteric neuronal development by endothelin-3: mediation by endothelin B receptors. , 1999, Development.

[34]  Y. Liu,et al.  Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells. , 2007, Human pathology.

[35]  M. Richardson,et al.  The neural crest population responding to endothelin-3 in vitro includes multipotent cells. , 1997, Journal of cell science.

[36]  Jian Wang,et al.  CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells , 2008, International journal of cancer.

[37]  M. Polokoff,et al.  Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. , 1994, Pharmacological reviews.

[38]  V. Pachnis,et al.  Maintenance of mammalian enteric nervous system progenitors by SOX10 and endothelin 3 signalling , 2006, Development.

[39]  Hong Wang,et al.  Stimulation of Endothelin B Receptors in Astrocytes Induces cAMP Response Element-Binding Protein Phosphorylation and c-fos Expression Via Multiple Mitogen-Activated Protein Kinase Signaling Pathways , 2001, The Journal of Neuroscience.

[40]  G. Liang,et al.  The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. , 2001, Human molecular genetics.

[41]  P. Patterson,et al.  Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor , 2008, BMC Cancer.

[42]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[43]  P. Corvol,et al.  Ontogeny of endothelins-1 and -3, their receptors, and endothelin converting enzyme-1 in the early human embryo. , 1998, The Journal of clinical investigation.

[44]  S. Nelson,et al.  Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors , 2009, Journal of Neuro-Oncology.

[45]  S. Shibata,et al.  Enhanced Expression of an Endothelin ETA Receptor in Capillaries from Human Glioblastoma: A Quantitative Receptor Autoradiographic Analysis Using a Radioluminographic Imaging Plate System , 1994, Journal of neurochemistry.

[46]  K. Catt,et al.  Endothelins as Autocrine Regulators of Tumor Cell Growth , 1998, Trends in Endocrinology & Metabolism.

[47]  F. Spinella,et al.  Endothelin B Receptor Blockade Inhibits Dynamics of Cell Interactions and Communications in Melanoma Cell Progression , 2004, Cancer Research.

[48]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[49]  C. Lanni,et al.  Endothelin B receptor antagonists block proliferation and induce apoptosis in glioma cells. , 2010, Pharmacological research.

[50]  K. Aldape,et al.  YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma , 2005, Clinical Cancer Research.